Literature DB >> 27068477

Cdk1 Phosphorylates SPAT-1/Bora to Promote Plk1 Activation in C. elegans and Human Cells.

Yann Thomas1, Luca Cirillo2, Costanza Panbianco2, Lisa Martino1, Nicolas Tavernier1, Françoise Schwager2, Lucie Van Hove1, Nicolas Joly1, Anna Santamaria3, Lionel Pintard4, Monica Gotta5.   

Abstract

The conserved Bora protein is a Plk1 activator, essential for checkpoint recovery after DNA damage in human cells. Here, we show that Bora interacts with Cyclin B and is phosphorylated by Cyclin B/Cdk1 at several sites. The first 225 amino acids of Bora, which contain two Cyclin binding sites and three conserved phosphorylated residues, are sufficient to promote Plk1 phosphorylation by Aurora A in vitro. Mutating the Cyclin binding sites or the three conserved phosphorylation sites abrogates the ability of the N terminus of Bora to promote Plk1 activation. In human cells, Bora-carrying mutations of the three conserved phosphorylation sites cannot sustain mitotic entry after DNA damage. In C. elegans embryos, mutation of the three conserved phosphorylation sites in SPAT-1, the Bora ortholog, results in a severe mitotic entry delay. Our results reveal a crucial and conserved role of phosphorylation of the N terminus of Bora for Plk1 activation and mitotic entry.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27068477     DOI: 10.1016/j.celrep.2016.03.049

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  21 in total

1.  Genomewide association study for economic traits in the large yellow croaker with different numbers of extreme phenotypes.

Authors:  Liang Wan; L Dong; Shijun Xiao; Zhaofang Han; Xiaoqing Wang; Z Wang
Journal:  J Genet       Date:  2018-09       Impact factor: 1.166

2.  Re-investigating PLK1 inhibitors as antimitotic agents.

Authors:  Quentin Delacour; Olivier Gavet
Journal:  Mol Cell Oncol       Date:  2017-08-01

3.  CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma.

Authors:  Ling Li; Kang Huang; Huijia Zhao; Binyao Chen; Qifa Ye; Jiang Yue
Journal:  Cell Cycle       Date:  2020-04-10       Impact factor: 4.534

4.  Insulin Signaling Regulates the FoxM1/PLK1/CENP-A Pathway to Promote Adaptive Pancreatic β Cell Proliferation.

Authors:  Jun Shirakawa; Megan Fernandez; Tomozumi Takatani; Abdelfattah El Ouaamari; Prapaporn Jungtrakoon; Erin R Okawa; Wei Zhang; Peng Yi; Alessandro Doria; Rohit N Kulkarni
Journal:  Cell Metab       Date:  2017-03-09       Impact factor: 27.287

5.  Mitotic entry: The interplay between Cdk1, Plk1 and Bora.

Authors:  Alfonso Parrilla; Luca Cirillo; Yann Thomas; Monica Gotta; Lionel Pintard; Anna Santamaria
Journal:  Cell Cycle       Date:  2016-11-10       Impact factor: 4.534

6.  Bipartite binding of the N terminus of Skp2 to cyclin A.

Authors:  Susan Kelso; Stephen Orlicky; Jonah Beenstock; Derek F Ceccarelli; Igor Kurinov; Gerald Gish; Frank Sicheri
Journal:  Structure       Date:  2021-05-13       Impact factor: 5.871

7.  Effects of Sepantronium Bromide (YM-155) on the Whole Transcriptome of MDA-MB-231 Cells: Highlight on Impaired ATR/ATM Fanconi Anemia DNA Damage Response.

Authors:  Elizabeth A Mazzio; Charles A Lewis; Rashid Elhag; Karam F Soliman
Journal:  Cancer Genomics Proteomics       Date:  2018 Jul-Aug       Impact factor: 3.395

8.  BORA-dependent PLK1 regulation: A new weapon for cancer therapy?

Authors:  Luca Cirillo; Yann Thomas; Lionel Pintard; Monica Gotta
Journal:  Mol Cell Oncol       Date:  2016-06-27

9.  Cell cycle protein Bora serves as a novel poor prognostic factor in multiple adenocarcinomas.

Authors:  Qiong-Xia Zhang; Rui Gao; Jin Xiang; Zhong-Yu Yuan; Yuan-Min Qian; Min Yan; Zi-Feng Wang; Quentin Liu; Hai-Dong Zhao; Chang-Hong Liu
Journal:  Oncotarget       Date:  2017-07-04

10.  Inhibition of Polo-like kinase 1 during the DNA damage response is mediated through loss of Aurora A recruitment by Bora.

Authors:  W Bruinsma; M Aprelia; I García-Santisteban; J Kool; Y J Xu; R H Medema
Journal:  Oncogene       Date:  2016-10-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.